A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
11/2004
11/09/2004	CA2044853C Method for treating parkinson's disease employing an atp-sensitive potassium channel blocker
11/04/2004	WO2004094622A2 Extracellular messengers
11/04/2004	WO2004094599A2 Disease prevention and vaccination following thymic reactivation
11/04/2004	WO2004094409A1 Novel ido inhibitors and methods of use
11/04/2004	WO2004094373A2 A method of providing a steroid-sparing benefit with a cyclooxygenase-2 inhibitor and compositions therewith
11/04/2004	WO2004094370A2 Antibacterial pyrazole carboxylic acid hydrazides
11/04/2004	WO2004093995A2 Use of antioxidants to treat bone loss disorders
11/04/2004	WO2004093914A1 Formulations for treatment of pulmonary disorders comprising a bronchodilator, a vasoconstrictor and a corticosteroid
11/04/2004	WO2004093913A1 Treatment of hypertension
11/04/2004	WO2004093911A1 Pharmaceutical composition for prostatic disease treatment
11/04/2004	WO2004093896A1 Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of central nervous system damage
11/04/2004	WO2004093895A1 Compositions of a cyclooxygenase-2 selective inhibitor and a potassium ion channel modulator for the treatment of pain, inflammation or inflammation mediated disorders
11/04/2004	WO2004093881A2 Use of dipyridamole or mopidamole for treatment and prevention of thrombo-embolic diseases and disorders caused by excessive formation of thrombin and/or by elevated expression of thrombin receptors
11/04/2004	WO2004093874A1 Use of 7-nitro-2,1,3 benzoxadiazole derivatives for anticancer therapy
11/04/2004	WO2004093871A1 Novel methods for the treatment of cancer
11/04/2004	WO2004093870A1 Treatment and prevention of otic disorders
11/04/2004	WO2004093868A1 Therapeutic combination of a cox-2 inhibitor and an aromatase inhibitor
11/04/2004	WO2004093863A1 A composition comprising an edible acid or its acidic salt and the use thereof
11/04/2004	WO2004093862A1 Pharmaceutical composition comprising edible acids or the acid salts and its use
11/04/2004	WO2004093856A2 Combination of a cox-2 inhibitor and an alkylating-type antineoplastic agent for treatment of neoplasia
11/04/2004	WO2004093828A2 Reverse-turn mimetics and method relating thereto
11/04/2004	WO2004093816A2 Compositions comprising a selective cox-2 inhibitor and a calcium modulating agent
11/04/2004	WO2004093814A2 Compositions of a cyclooxygenase-2 selective inhibitor and a sodium channel blocker
11/04/2004	WO2004093813A2 Compositions of a cyclooxygenase-2 selective inhibitor and a calcium modulating agent for the treatment of pain, inflammation or inflammation mediated disorders
11/04/2004	WO2004093811A2 Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of central nervous system damage
11/04/2004	WO2004093801A2 Pharmaceutical products
11/04/2004	WO2004093795A2 Compositions for delivery of drug combinations
11/04/2004	WO2004093794A2 Antimicrobial medical articles containing a combination of anti-infective compounds, octoxyclycerin, salicylic acid, and sesquiterpenoids
11/04/2004	WO2004076349B1 Therapeutic malonic acid/acetic acid c60 tri-adducts of buckminsterfullerene and methods related thereto
11/04/2004	WO2004069254A3 Use of dipyridamole or mopidamole for treatment and prevention of mmp-9-dependent disorders
11/04/2004	WO2004069143A3 Treatment of inflammatory bowel disease
11/04/2004	WO2004066990A3 Methods of treating lower urinary tract disorders using sodium channel modulators
11/04/2004	WO2004066987A3 Use of sodium channel modulators for treating gastrointestinal tract disorders
11/04/2004	WO2004060319A3 Immunostimulatory combinations
11/04/2004	WO2004056353A3 Device and method for delivering mmp inhibitors
11/04/2004	WO2004052177A3 Cell-based therapies for ischemia
11/04/2004	WO2004043340A3 Alpha 5 beta 1 and its ability to regulate the cell survival pathway
11/04/2004	WO2004039412A3 Compositions for cancer treatment
11/04/2004	WO2004026259A3 Transdermal compositions
11/04/2004	WO2004004652A3 Mitotic kinesin binding site
11/04/2004	WO2004003000A3 1’-, 2'- and 3'- modified nucleoside derivatives for treating flaviviridae infections
11/04/2004	WO2003091403A3 Genetic and epigenetic manipulation of abc transporters and ecto-phosphatases
11/04/2004	WO2003090753A8 Pharmaceutical combination for the treatment of benign prostatic hyperplasia or for the long-term prevention of acute urinary retention
11/04/2004	WO2003090512A3 Regeneration of endogenous myocardial tissue by induction of neovascularization
11/04/2004	WO2003089903A3 Compositions and methods relating to endothelial cell signaling using the protease activated receptor (par1)
11/04/2004	WO2003086324A3 Preparation and use of a stable formulation of allosteric effector compounds
11/04/2004	WO2003076593A3 Genomic screen for epigenetically silenced genes associated with cancer
11/04/2004	WO2003063799A3 Compositions and methods for systemic inhibition of cartilage degradation
11/04/2004	WO2003000183A3 Method of treating atherosclerosis and other inflammatory diseases
11/04/2004	US20040220408 As anti-proliferative agents, therapy
11/04/2004	US20040220392 Compositions for, and methods of, treating atherosclerosis
11/04/2004	US20040220283 Aqueous 2,6-diisopropylphenol pharmaceutical compositions
11/04/2004	US20040220276 Coated granules of allylamine-or benzylamine-anti-mycotics
11/04/2004	US20040220274 Synergistic mixture of neurokinin receptor antagonist and phosphodiesterase inhibitor
11/04/2004	US20040220246 2-imidazomethyl- pyrido(4,3-b)indol-1-one or -carbazol-1-one derivatives containing an ester group; especially for treating irritable bowel syndrome.
11/04/2004	US20040220209 Novel imidazopyridine compounds with therapeutic effect
11/04/2004	US20040220203 Method and composition for potentiating an opiate analgesic
11/04/2004	US20040220202 antiinflammatory agents; central nervous system disorders; controlling cell proliferation, cell differentiation; anticancer agents; antidepressants
11/04/2004	US20040220190 Methods of treating metabolic syndrome using dopamine receptor agonists
11/04/2004	US20040220187 Compositions of a cyclooxygenase-2 selective inhibitor and a sodium ion channel blocker for the treatment of pain, inflammation or inflammation mediated disorders
11/04/2004	US20040220184 Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)
11/04/2004	US20040220181 Adhesive antineoplastic compositions
11/04/2004	US20040220173 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
11/04/2004	US20040220171 anticoagulants; immunomoderators; antiinflammatory agents
11/04/2004	US20040220163 Contraceptive method and composition
11/04/2004	US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004	US20040220155 administering mixture of cyclooxygenase inhibitor and corticosteroid
11/04/2004	US20040220153 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
11/04/2004	US20040220141 Method for producing purified hematinic iron-saccharidic complex and product produced
11/04/2004	US20040220134 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220121 Methods for drug delivery
11/04/2004	US20040220119 flavonoids for therapy, prevention skin disorders; topical administering
11/04/2004	US20040220118 balancing s-adenosylmethionine; administering synergistic mixture containing isoflavone
11/04/2004	US20040220096 Method and compositions for treating dopaminergic and gabanergic disorders
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040219644 Immunoglobulin for binding monocyte chemoattractant protein-1(MCP-1) and preventing and/or treating atherosclerosis and cancer ; antitumor agents
11/04/2004	US20040219640 Polypeptides homologous to VEGFand BMPI
11/04/2004	US20040219632 T1r3 a novel taste receptor
11/04/2004	US20040219575 Using presence of transcription factor/tumor antigen splice variant to diagnose cell proliferative disorders; tumor cell characterization
11/04/2004	US20040219240 hops extracts or derivatives, in combination with an analgesic compound and/or an anti-inflammatory compound for reducing gastroenteropathy or gastric toxicity, including ulcerogenic-type disorders
11/04/2004	US20040219229 Migraine relief composition and methods of using and forming same
11/04/2004	US20040219220 Therapeutic agents
11/04/2004	US20040219211 a tablet which disintigrates in the mouth, having enterically coated microgranules of a benzimidazole type proton pump inhibitor overcoated with a methacrylic copolymer protective coating, granular antacids, a disintegrating agent, a diluent, and a lubricant; gastrointestinal disorders
11/04/2004	US20040219208 Sustained-release medicines
11/04/2004	US20040219207 Drug preparation comprising alpha-lipoic acid, ambroxol and/or inhibitors of the angiotensin-converting enzyme (ACE) and its use for the treatment of neurodegenerative diseases
11/04/2004	US20040219201 Tempamine compositions and methods of use
11/04/2004	US20040219188 Composition and methods for nutritional management of patients with hepatic disease
11/04/2004	US20040219176 dosage form of a mixture of drugs, foaming agents and gases, having improved pharmacokinetics; drug delivery systems
11/04/2004	US20040219174 Contraception process and administration form for the same
11/04/2004	US20040219173 Administring the sodium chloride formulation to the human's upper gastro-intestinal tract so as to introduce the sodium chloride formulation to the metabolism of the human with periodical repetition
11/04/2004	US20040219165 Streptococcus pneumoniae antigens
11/04/2004	US20040219160 Zwitterionic immunomodulators for the treatment of asthma and allergy
11/04/2004	US20040219157 Composition comprising a prebiotic for decreasing inflammatory process and abnormal actibation of non-specific immune parameters
11/04/2004	US20040219153 Synergistic tumorcidal response induced by histamine
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	US20040219144 administering an anti-human NGF monoclonal antibody capable of binding hNGF with an affinity in the nanomolar range, and inhibiting the binding of hNGF to human TrkA (hTrkA) in vivo, wherein said antibody has no significant adverse effect on the immune system
11/04/2004	US20040219136 Use of umbilical cord blood to treat individuals having a disease, disorder or condition
11/04/2004	US20040219133 cells are dispersed using an air-jet sprayer after being suspended in a soluble media either directly onto the area or onto a tissue scaffold to form three dimensional epithelial tissue
11/04/2004	US20040219130 Hyperthermia agent for malignant tumor comprising cytokine and magnetic fine particles

1 ... 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 ... 1151